Hancock Jaffe Laboratories, Inc. — Form D

Hancock Jaffe Laboratories, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-04. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Robert Andrew BermanDirectorIrvine, CA
Francis C DuhayDirectorIrvine, CA
Robert C GrayDirectorIrvine, CA
Matthew M JenusaitisDirectorIrvine, CA
Sanjay Andrew ShrivastavaDirectorIrvine, CA
Robert Andrew BermanExecutive OfficerIrvine, CA
Mark H GlickmanExecutive OfficerIrvine, CA
Craig Andrew GlynnExecutive OfficerIrvine, CA
Robert AndersonDirectorVANCOUVER, A1
Sanjay ShrivastavaRelated PersonHayward, CA
WILLIAM ABBOTTExecutive OfficerMANSFIELD, MA
Yury ZhiviloDirectorIrvine, CA
Yury ZhiviloExecutive OfficerIrvine, CA
Yury ZhiviloRelated PersonIrvine, CA
Robert DoyleDirectorVancouver, A1
Robert A BermanDirectorIrvine, CA
Robert A BermanExecutive OfficerIrvine, CA
Sanjay A ShrivastavaDirectorIrvine, CA
Francis A Duhay, M.D.DirectorIrvine, CA
Marc H Glickman, M.D.Executive OfficerIrvine, CA
Robert H RankinExecutive OfficerIrvine, CA
Francis DuhayRelated PersonIrvine, CA
Francis A DuhayDirectorIrvine, CA
Benedict Broennimann, MDExecutive OfficerIrvine, CA
Gennady AlferenkoDirectorIrvine, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-03-10D$890K$650K
2019-05-03D/A$2.7M$2.7M
2019-04-16D$2.7M$2.7M
2017-06-26D$2.0M$1.0M
2017-03-22D$7.5M$194K
2015-12-15D$6.5M$680K

More